Medication info

Simastan (Losartan Potassium)

Prescription medicationExpired
Ingredient · strength
Losartan Potassium›Strength being verified
Manufacturer / importer
Mirae Bio Pharmaceutical Co., Ltd.
Appearance
White oval film-coated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Expired

MFDS item code 201307392 · Approved 2013.05.21

This product's status changed to Expired on 2023.05.21. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of hypertension and renal disease in patients with type 2 diabetes accompanied by hypertension
Who uses it
Adults · Children
Adult dosage
1. Hypertension The initial and maintenance dose is 50mg once daily, with or without food. The maximum blood pressure-lowering effect is achieved 3 ~ 6 weeks after starting treatment. If necessary, the dose may be increased to 100mg once daily. 1) Elderly patients: No adjustment of the initial dose is necessary for patients 75 years of age or younger. For patients over 75 years of age, an initial dose of 25mg once daily is recommended. 2) Patients with renal impairment: No adjustment of the initial dose is necessary for patients with mild renal impairment (I.e. creatinine clearance 20 ~ 50mL/min). An initial dose of 25mg once daily is recommended for patients with moderate ~ severe renal impairment (i.e. creatinine clearance <20mL/min) and for patients undergoing dialysis. 3) Patients with reduced effective intravascular volume For patients who may have reduced effective intravascular volume (e.g., patients receiving diuretics), an initial dose of 25 mg once daily of this drug is recommended (see the Precautions for Use section). 4) Patients with hepatic impairment: A lower dose should be considered for patients with a history of hepatic impairment. 6) If blood pressure is not controlled with this drug alone, it may be administered in combination with other antihypertensive drugs (e.g. a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. 2. Treatment of renal disease in patients with type 2 diabetes and hypertension The initial dose is 50mg once daily. Depending on blood pressure, the dose may be increased to 100mg once daily. This drug may be administered in combination with insulin and commonly used antidiabetic drugs (e.g., sulfonylureas, glitazones, glucosidase inhibitors).
Children's dosage
5) Pediatric and adolescent patients aged 6 years and older: For patients weighing 20kg or more but less than 50kg who are able to swallow tablets, the recommended initial dose is 25mg once daily, which may be increased to a maximum of 50mg once daily depending on the patient's blood pressure response. For patients weighing 50kg or more, the initial dose is 50mg once daily, which may be increased to 100mg once daily. Not recommended for pediatric patients under 6 years of age. Not recommended for pediatric patients with a glomerular filtration rate of less than 30mL/min/1.73㎡. Not recommended for pediatric patients with hepatic impairment.

Ingredients

Manufacturer
Mirae Bio Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of hypertension and renal disease in patients with type 2 diabetes accompanied by hypertension

  • Hypertension
  • kidney disease in patients with type 2 diabetes
View approved original text

This medication is used to treat hypertension. It is particularly effective in patients with hypertension caused by kidney disease among those with type 2 diabetes. Therefore, it helps reduce cardiovascular risks associated with hypertension and protects kidney function. This medication contributes to improving patient health by reliably managing blood pressure.

Dosage and Administration

Adult dosage

1. Hypertension The initial and maintenance dose is 50mg once daily, with or without food. The maximum blood pressure-lowering effect is achieved 3 ~ 6 weeks after starting treatment. If necessary, the dose may be increased to 100mg once daily. 1) Elderly patients: No adjustment of the initial dose is necessary for patients 75 years of age or younger. For patients over 75 years of age, an initial dose of 25mg once daily is recommended. 2) Patients with renal impairment: No adjustment of the initial dose is necessary for patients with mild renal impairment (I.e. creatinine clearance 20 ~ 50mL/min). An initial dose of 25mg once daily is recommended for patients with moderate ~ severe renal impairment (i.e. creatinine clearance <20mL/min) and for patients undergoing dialysis. 3) Patients with reduced effective intravascular volume For patients who may have reduced effective intravascular volume (e.g., patients receiving diuretics), an initial dose of 25 mg once daily of this drug is recommended (see the Precautions for Use section). 4) Patients with hepatic impairment: A lower dose should be considered for patients with a history of hepatic impairment. 6) If blood pressure is not controlled with this drug alone, it may be administered in combination with other antihypertensive drugs (e.g. a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. 2. Treatment of renal disease in patients with type 2 diabetes and hypertension The initial dose is 50mg once daily. Depending on blood pressure, the dose may be increased to 100mg once daily. This drug may be administered in combination with insulin and commonly used antidiabetic drugs (e.g., sulfonylureas, glitazones, glucosidase inhibitors).

Children's dosage

5) Pediatric and adolescent patients aged 6 years and older: For patients weighing 20kg or more but less than 50kg who are able to swallow tablets, the recommended initial dose is 25mg once daily, which may be increased to a maximum of 50mg once daily depending on the patient's blood pressure response. For patients weighing 50kg or more, the initial dose is 50mg once daily, which may be increased to 100mg once daily. Not recommended for pediatric patients under 6 years of age. Not recommended for pediatric patients with a glomerular filtration rate of less than 30mL/min/1.73㎡. Not recommended for pediatric patients with hepatic impairment.

Precautions

This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so it should not be taken by pregnant women or women who may become pregnant. If pregnancy is confirmed, the medication should be discontinued immediately, and regular examinations to check the health of the fetus are necessary. This medication should not be administered to patients with severely impaired liver function, certain hereditary diseases, or specific kidney diseases. Caution is required in elderly patients, patients with hyperkalemia, and patients with mild to moderate liver dysfunction, as blood pressure may drop too low. As this medication lowers blood pressure, dizziness or fainting may occur while taking it, so caution is necessary when driving or operating machinery. It is safe not to take this medication with potassium supplements or medications containing potassium, as it can elevate potassium levels. Regular checks of blood pressure, kidney function, electrolyte levels, etc., should be done during use to confirm any abnormalities. Rarely, side effects such as liver dysfunction, blood abnormalities, muscle pain, and skin rashes may occur, so if any unusual symptoms appear, contact a doctor immediately. This medication is not recommended for breastfeeding women, and if it needs to be taken, it is advisable to stop breastfeeding. In case of overdose, hypotension and cardiac arrhythmias may occur, so appropriate treatment should be sought immediately at a medical facility.

Side effects

  • Craniosynostosis
  • anuria
  • hypotension
  • renal failure
  • death
  • muscle spasm
  • lumbar pain
  • limb pain
  • dizziness
  • congestion
Show 131 more
  • upper respiratory infection
  • sinusitis
  • nausea
  • diarrhea
  • dyspepsia
  • cough
  • sinus disorder
  • pharyngitis
  • myalgia
  • insomnia
  • headache
  • weakness
  • fatigue
  • edema
  • swelling
  • abdominal pain
  • chest pain
  • lip swelling
  • eyelid swelling
  • facial rash
  • hemolysis
  • facial edema
  • fever
  • orthostatic effect
  • syncope
  • angina pectoris
  • second-degree atrioventricular block
  • cerebrovascular accident
  • myocardial infarction
  • atrial fibrillation
  • arrhythmia
  • palpitations
  • bradycardia
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • loss of appetite
  • constipation
  • toothache
  • dry mouth
  • flatulence
  • gastritis
  • vomiting
  • anemia
  • gout
  • upper limb pain
  • hip pain
  • joint swelling
  • knee pain
  • myasthenia
  • arthralgia
  • arthritis
  • fibromyalgia
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory impairment
  • decreased libido
  • memory impairment
  • migraine
  • neurohyperesthesia
  • sensory abnormality
  • peripheral neuropathy
  • panic disorder
  • sleep disorder
  • narcolepsy
  • tremor
  • dyspnea
  • bronchitis
  • pharyngeal discomfort
  • epistaxis
  • rhinitis
  • respiratory congestion
  • chest discomfort
  • alopecia
  • dermatitis
  • dry skin
  • petechiae
  • erythema
  • flushing
  • photosensitivity reaction
  • itching
  • rash
  • sweating
  • hives
  • blurred vision
  • eye burning
  • pain
  • conjunctivitis
  • taste disturbance
  • tinnitus
  • vision impairment
  • erectile dysfunction
  • nocturia
  • frequency
  • urethral infection
  • vascular edema
  • vasculitis
  • anaphylactic-like syndrome
  • liver dysfunction
  • hepatitis
  • malaise
  • thrombocytopenia
  • myalgia
  • weakness
  • elevated creatine kinase
  • rhabdomyolysis
  • taste disturbance
  • dry cough
  • erythema multiforme
  • hyperkalemia
  • hyponatremia
  • elevated ALT
  • increased creatinine
  • increased BUN
  • decreased hemoglobin
  • decreased hematocrit
  • elevated liver enzymes
  • increased serum bilirubin
  • syncope
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • ventricular ectopic contractions
  • hypoglycemia
  • hypotension
  • tachycardia
  • bradycardia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air or moisture from entering. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

White oval film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.